Poolbeg Pharma PLC
Harnessing AI and Solidifying IP to Revolutionize Infectious Disease Treatment
By Alex Langton | 3 October 2023
Poolbeg Pharma (POLB.L) stands out as a beacon of innovation in the rapidly evolving world of biopharmaceuticals. With a primary focus on infectious and other prevalent diseases, the company is making significant strides in drug discovery and development, particularly with its flagship POLB001.
A Spin-Out with a Vision
In 2β¦